Alnylam Pharmaceuticals
ALNY
#522
Rank
โ‚น4.204 T
Marketcap
โ‚น31,828
Share price
3.74%
Change (1 day)
33.34%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company